You are here

  • Home
  • Archive
  • Volume 62, Issue 3
  • A meta-analysis for percutaneous tumour ablation in patients with small hepatocellular carcinoma: highlighting combined strategy in the future

Article Text

Article menu
Download PDFPDF
PostScript
Letter
A meta-analysis for percutaneous tumour ablation in patients with small hepatocellular carcinoma: highlighting combined strategy in the future
  1. Zi Yin1,
  2. Dong Yin2,
  3. Jie Wang1
  1. 1General Surgery Department, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, Guangzhou, Guangdong, China
  2. 2Division of Hematology and Oncology, Cedars-Sinai Medical Center, University of California at Los Angeles School of Medicine, Los Angeles, California, USA
  1. Correspondence to Dr Jie Wang, General Surgery Department, Sun Yat-sen Memorial Hospital of Sun Yat-sen University, 107 Yanjiang West Rd, Guangzhou, Guangdong 510120, China; wjsunyatsen{at}gmail.com

https://doi.org/10.1136/gutjnl-2012-303584

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    We read with great interest the leading article by Tremosini et al in Gut (2012 doi:10.1136/gutjnl-2011-301951) which prospectively assessed the diagnostic accuracy of an immunohistochemical panel (glypican 3, heat shock protein 70 and glutamine synthetase) in patients with cirrhosis with a small (5–20 mm) nodule detected by ultrasound screening.1 Finally, they established the clinical usefulness of that panel of markers for the diagnosis of early hepatocellular carcinoma (HCC). Then, something that logically or naturally follows from the early detection would be the treatment for early small HCC, that is, what the real role of each early modality plays in clinical practice.

    Surveillance programmes for early detection of small nodular-type HCC have increased the number of patients suitable for surgical treatment. However, unlike other solid tumours, surgical resection plays a limited role in patients with HCC because of the lack of hepatic reserve as a result of coexisting cirrhosis or the presence of multiple tumours. Besides, liver …

    View Full Text

    Footnotes

    • Contributors We certify that we have participated sufficiently in the work to take public responsibility for the appropriateness of the design and method. In addition, all authors of this research paper have directly participated in the planning and execution, and the collection, analysis and interpretation of the data. Also, all authors of this paper have read and approved the final version submitted. ZY: data collection and elaboration, statistical analysis, writing of the manuscript; DY: data collection and elaboration, statistical analysis; JW: data collection and elaboration. ZY and DY contributed equally to this manuscript.

    • Competing interests None.

    • Ethics approval This was a meta-analysis, and all the included RCTs have obtained this approval from their own institutions.

    • Provenance and peer review Not commissioned; internally peer reviewed.